| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/26/2007 | WO2007027230A3 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 04/26/2007 | WO2007026024A3 Benzodiazepines as hcv inhibitors |
| 04/26/2007 | WO2007025774A3 Cysteine protease inhibitors |
| 04/26/2007 | WO2007025284A8 Triazole compounds and methods of making and using the same |
| 04/26/2007 | WO2007025098A3 Triazole compounds and methods of making and using the same |
| 04/26/2007 | WO2007024501A3 Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore |
| 04/26/2007 | WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 04/26/2007 | WO2007021721A3 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas |
| 04/26/2007 | WO2007020527A3 Process for the preparation of strontium ranelate |
| 04/26/2007 | WO2007020277A3 Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes |
| 04/26/2007 | WO2007019503A3 Management of ophthalmologic disorders, including macular degeneration |
| 04/26/2007 | WO2007017754A3 Androgen modulators |
| 04/26/2007 | WO2007017511A3 Compounds for treating alzheimer's disease |
| 04/26/2007 | WO2007017267A3 Novel compounds |
| 04/26/2007 | WO2007017244A3 A PROCESS FOR THE PURIFICATION OF SUBSTITUTED 2-(2-PYRIDYLMETHYL)SULFINYL-lH-BENZIMIDAZOLE COMPOUNDS BY PRECIPITATION IN THE PRESENCE OF A QUATERNARY AMMONIUM SALT |
| 04/26/2007 | WO2007017145A3 Gsk-3 inhibitors |
| 04/26/2007 | WO2007017126A3 POLYMORPH OF N-PIPERIDINYL-5- (4-CHLOROPHENYL) -1- (2, 4-DICHLOROPHENYL) -4, 5-DIHYDRO-lH-PYRAZOLE- 3 -CARBOXAMIDE AND ITS USE AS A CAMNABINOID RECEPTOR MODULATOR |
| 04/26/2007 | WO2007014839A3 Cathepsin k inhibitors |
| 04/26/2007 | WO2007014762A3 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 04/26/2007 | WO2007013868A3 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 04/26/2007 | WO2007012671A3 Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method |
| 04/26/2007 | WO2007012479A3 Benzylpiperazine derivates and their medical use |
| 04/26/2007 | WO2007011764A3 Drospirenone containing transdermal drug delivery devices and methods of delivery thereof |
| 04/26/2007 | WO2007011594A3 Highly selective serotonin and norepinephrine dual reuptake inhibitor and use thereof |
| 04/26/2007 | WO2007009699A3 Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases |
| 04/26/2007 | WO2007009683A3 Pharmaceutical formulations of substituted pyrazoline compounds |
| 04/26/2007 | WO2007008752A3 Sustained release pharmaceutical compositions for highly water soluble drugs |
| 04/26/2007 | WO2007007189A3 Metformin methods and formulations for treating chronic constipation |
| 04/26/2007 | WO2007005534A3 Chemical compounds |
| 04/26/2007 | WO2007003435A3 Use of activators of the soluble guanylate cyclase for promoting the healing of wounds |
| 04/26/2007 | WO2007001839A3 4-anilino-3-quinolinecarbonitriles for the treatment of cancer |
| 04/26/2007 | WO2006138608A3 Pharmaceutical compositions and use thereof |
| 04/26/2007 | WO2006136606A3 Oxindole derivatives |
| 04/26/2007 | WO2006135828A3 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 04/26/2007 | WO2006135635A3 Topical compositions and methods for alleviating or inhibiting symptoms associated with carpal tunnel syndrome, acid reflux, psoriasis, cartilage nodules, fibromyalgia, and diabetes |
| 04/26/2007 | WO2006133216A3 4-substituted arylamine derivatives and their use in pharmaceutical compositions |
| 04/26/2007 | WO2006133104A3 Benzoimidazolone-carboxamide compounds as 5-ht4 receptor agonists |
| 04/26/2007 | WO2006133048A3 Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same |
| 04/26/2007 | WO2006131833A3 New hybrid oligomers. their preparation process and pharmaceutical compositions containing them |
| 04/26/2007 | WO2006128847A3 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
| 04/26/2007 | WO2006128600A3 Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine |
| 04/26/2007 | WO2006128268A8 Ureidic compounds, pharmaceutical compositions containing the same and their use on the treatment of inflammatory diseases |
| 04/26/2007 | WO2006127930A3 Nk-b inhibitors for the treatment of muscular dystrophy |
| 04/26/2007 | WO2006125815A3 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 04/26/2007 | WO2006123247A3 Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands |
| 04/26/2007 | WO2006122771A3 Substituted benzo-condensed cyclohexanone derivatives and the use thereof for medicament production |
| 04/26/2007 | WO2006121560A8 Methods and compositions for treatment of cns disorders |
| 04/26/2007 | WO2006117686A3 Compounds that stimulate glucose utilization and methods of use |
| 04/26/2007 | WO2006117307B1 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 04/26/2007 | WO2006117300A3 Crystalline forms of tiotropium bromide |
| 04/26/2007 | WO2006117165A3 Means and methods for the treatment of head injuries and stroke |
| 04/26/2007 | WO2006113990B1 LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1α ,25-DIHYDROXY VITAMIN D3 |
| 04/26/2007 | WO2006110187A3 Methods and compositions for the treatment of anxiety disorders |
| 04/26/2007 | WO2006108643A3 Organic compounds |
| 04/26/2007 | WO2006108039A3 Substituted azetidinones |
| 04/26/2007 | WO2006099233A3 Compositions and methods for the treatment of osteoporosis and inflammatory joint disease |
| 04/26/2007 | WO2006099121A3 Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof |
| 04/26/2007 | WO2006099075A3 Certain substituted amides, method of making, and method of use thereof |
| 04/26/2007 | WO2006097809A3 Novel tyrosine derivatives |
| 04/26/2007 | WO2006089871A3 Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias |
| 04/26/2007 | WO2006089076A9 Thiazole amides, imidazole amides and related analogues |
| 04/26/2007 | WO2006086617A9 Polyethylene oxide polymers including anti-inflammatory glycodendrons |
| 04/26/2007 | WO2006085672A3 Production of polyunsaturated fatty acids using novel cell treatment method |
| 04/26/2007 | WO2006084199A3 Nitroxides for use in treating or preventing amyloid-related diseases |
| 04/26/2007 | WO2006081546A3 Inhibitor nucleic acids |
| 04/26/2007 | WO2006074951A3 Orally disintegrating composition of olanzapine or donepezil |
| 04/26/2007 | WO2006073724A3 Use of certain phenyl napthyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms) |
| 04/26/2007 | WO2006067165A3 Indolidone derivatives for the treatment or prevention of fibrotic diseases |
| 04/26/2007 | WO2006060301A3 Starch derivatives and other derivatives, production processes therefor, and wound healing applications therefor |
| 04/26/2007 | WO2006059247A8 VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC |
| 04/26/2007 | WO2006053121A3 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 04/26/2007 | WO2006045041A3 Methods for microbial biofilm destruction and interference with microbial cellular physiology |
| 04/26/2007 | WO2006040569A8 Thiophene amide compounds for use in the treatment or prophylaxis of cancers |
| 04/26/2007 | WO2006040112A3 Taste-masking pharmaceutical compositions |
| 04/26/2007 | WO2006039356A8 Substituted n-aryl-9-oxo-9h-fluorene-1-carboxamides and analogs as activators of caspases and inducers of apoptosis |
| 04/26/2007 | WO2006031676A3 Tricyclic anilide spirohydantoin cgrp receptor antagonists |
| 04/26/2007 | WO2006029223A3 Method for stimulating the immune response of newborns |
| 04/26/2007 | WO2006029075A8 Fibrate compounds having ppar agonist activity |
| 04/26/2007 | WO2006017921A8 Selective muscle relaxant and pharmaceutical compositions |
| 04/26/2007 | WO2005115991A8 Anti-cytokine heterocyclic compounds |
| 04/26/2007 | WO2005115390A3 Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses |
| 04/26/2007 | WO2005112921A3 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| 04/26/2007 | WO2005105110A3 Doxepin analogs and methods of use thereof |
| 04/26/2007 | WO2005094554A3 Therapeutic agents, methods, and treatments |
| 04/26/2007 | WO2005094268A3 Treatment and prophylaxis of sepsis and septic shock |
| 04/26/2007 | WO2005090359A3 Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof |
| 04/26/2007 | WO2005087728A9 Resistance-repellent retroviral protease inhibitors |
| 04/26/2007 | WO2005082883A3 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline |
| 04/26/2007 | WO2005041859A3 Conjugates and compositions for cellular delivery. |
| 04/26/2007 | WO2005035441A3 Subtituted fullerene compositions and their use as antioxydants |
| 04/26/2007 | WO2005034847A3 Methods of reducing risk of infection from pathogens |
| 04/26/2007 | WO2005012304A3 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 04/26/2007 | WO2004069139A3 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 04/26/2007 | US20070093677 Creatine salts and method of making same |
| 04/26/2007 | US20070093659 Methyl-2-[4-methyl-2-(1-methyl-piperidin-4-ylamino)-benzoimidazol-1-ylmethyl]-pyridin-3-ol; antiviral activity |
| 04/26/2007 | US20070093658 used for the treatment of a cancer in mammals; anticarnogenic or antitumor agents |
| 04/26/2007 | US20070093557 Sertraline hydrochloride form II and methods for the preparation thereof |
| 04/26/2007 | US20070093556 Toremifene crystallization method |
| 04/26/2007 | US20070093555 Topical pain relief compositions of N,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
| 04/26/2007 | US20070093554 Agent for improving feeling of cold |